I (Don’t) Want My MTV: Higher Metabolic Tumor Volume Predicts Poor Outcomes in Second-Line Large B-Cell Lymphoma, Although Axi-Cel Still Outperforms Standard of Care

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Hematologist

Topics

Computer Science

Cancer Oncology

Mathematics

Physics

Medicine

Show all topics

DOI

10.1182/hem.v21.5.202451